Ivermectin and Human Immunity

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 12, 2018

Primary Completion Date

April 9, 2018

Study Completion Date

November 30, 2018

Conditions
Ivermectin
Interventions
DRUG

Ivermectin

150 mcg/kg ivermectin, by mouth.

OTHER

Placebo

An oral placebo will be administered, once

Trial Locations (1)

30602

University of Georgia, Athens

All Listed Sponsors
lead

University of Georgia

OTHER

NCT03459794 - Ivermectin and Human Immunity | Biotech Hunter | Biotech Hunter